A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Phase 1 study, condition: Healthy. The main purpose of this study is to look at the amount of the study drug, LY3437943, that gets into the blood stream and how long it takes the body to get rid of it when given using two different devices. The study will also evaluate the safety and tolerability of LY3437943 and information about any side effects experienced will be collected. For each participant, the total duration of the study will be approximately 16 weeks, including screening. Enrolment: 57 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.